Home - EnsoData
EnsoData is a U.S.-based healthcare technology company that provides AI-powered solutions that connect diagnosis to therapy in sleep medicine.| EnsoData
The home sleep apnea testing (HSAT) market is evolving rapidly. If you are still using outdated, single-use, or expensive solutions, your sleep program could be falling behind. In this blog, discover why now is the time to switch from your legacy based or ineffective home sleep testing solution to EnsoSleep PPG™. The post Why Now Is the Time to Switch Your Home Sleep Testing Solution appeared first on EnsoData.| EnsoData
AI-based polysomnography (PSG) algorithm to be developed, validated, and integrated into EnsoData’s EnsoSleep AI Scoring and Study Management platform. Partnership offers potential to enable accurate, scalable NT1 identification earlier in the care journey using PSG and address the unmet need for more timely diagnosis. The post EnsoData Announces Collaboration with Takeda to Improve Narcolepsy Type 1 Diagnostic Journey Using AI Tools and Technology appeared first on EnsoData.| EnsoData
EnsoData is a U.S.-based healthcare technology company that provides AI-powered solutions that connect diagnosis to therapy in sleep medicine.| EnsoData
Multi-night home sleep testing with EnsoSleep PPG™ boosts diagnostic accuracy, reduces hardware costs, and results in better patient outcomes| EnsoData
EnsoData™ raises $20M Series B to accelerate commercialization of AI-powered sleep medicine solutions and extend capabilities to adjacent specialties| EnsoData
EnsoData Research work drives key product development and releases, including the Total Sleep Time and EnsoTherapy solutions.| EnsoData
This study suggests brain age is “malleable” and responsive to therapies that improve sleep and thus highlights its value as a potential biomarker of brain health. The post Is Brain Age Malleable to Sleep Apnea Therapy? An Exploratory Positive Airway Pressure Titration and Machine Learning-based Brain Age Study appeared first on EnsoData.| EnsoData
The results of this study highlight the ability to expand OSA screening using ECG-based machine learning systems. The post Clinical Validation of ECG-Based Obstructive Sleep Apnea Screening Using Machine Learning appeared first on EnsoData.| EnsoData
This study evaluates the Impact of Multi-Night Home Sleep Apnea Testing for Obstructive Sleep Apnea (OSA) Diagnosis. The post Evaluating the Impact of Multi-Night Home Sleep Apnea Testing for Obstructive Sleep Apnea Diagnosis appeared first on EnsoData.| EnsoData
This study explored whether PPG-based sleep stages are robust enough to detect sleep architectural abnormalities specifically associated with Narcolepsy Type-1.| EnsoData
EnsoData™, an innovator in AI solutions in sleep medicine, adds Bobby Cockrill, MBA, as Chief Commercial Officer, (CCO) to oversee strategy and execution of sales and marketing functions, grow a world-class team, and continue accelerating adoption across North America. The post EnsoData™ Appoints Chief Commercial Officer, Bobby Cockrill, MBA appeared first on EnsoData.| EnsoData
Partnership between EnsoData™, ABM, adds sleep position data captured by Night Shift™ to EnsoSleep PPG™ home sleep test| EnsoData
This study included standardized skin pigmentation assessments to enable bias analyses in EnsoData's PPG-Based OSA detection algorithm.| EnsoData
